Paclitaxel Phares

Paclitaxel, the active ingredient in Paclitaxel Phares, is a taxane antimicrobial presented as a injection for intravenous use. It treats various cancers in adult patients.

GNH USA supplies Paclitaxel Phares as a licensed, GDP‑compliant international pharmaceutical supplier serving oncology centres worldwide.

Paclitaxel is a chemotherapy agent that interferes ​​  ​  ​  ​  ​  ​  ​  ​  ​  ​  ​  ​  ​  ​  ​  ​  ​ ‑      ​  ​  ​  ​  ​  ​ ‑      ‑                ​  ​          ​ ​           ​ ​  ​         ​ ​

- Breast cancer: improves survival when used in combination regimens. - Ovarian cancer: reduces tumor progression in advanced disease. - Non‑small cell lung cancer: part of first‑line therapy for metastatic disease.